Home > Pill Identifier > Guaifenesin 400 MG / Phenylephrine 10 MG Oral Tablet

Pill Identifier Information of Guaifenesin 400 MG / Phenylephrine 10 MG Oral Tablet

Drug Information

Guaifenesin 400 MG / Phenylephrine 10 MG Oral Tablet

Imprint: RCCGPE;C27
Shape: C48345
Color: C48325
Ingredients: Guaifenesin; Phenylephrine
Size: 17.00
Score: 2
Rxtty: SCD
Author: Premier Value
Inactive Ingredients: CROSCARMELLOSE SODIUM / LACTOSE / MAGNESIUM STEARATE / MALTODEXTRIN / CELLULOSE, MICROCRYSTALLINE / POVIDONE / MAGNESIUM SILICATE>

Complete Information

  • ACTIVE INGREDIENT

    Guaifenesin                             400 mg

    Phenylephrine HCl                   10 mg

  • PURPOSE

    Guaifenesin                               Expectorant

    Phenylephrine HCl                   Nasal decongestant

  • INDICATIONS & USAGE

    temporarily relieves symptoms associated with a cough ,the common cold,hay fever or other upper respiratory allergies.

    helps loosen phlegm;mucus

    clear nasal passageways

    loosens nasal congestion

    drain bronchial tubes

    shrinks swollen membranes

    clears stuffy nose

    makes coughs more productive

  • WARNINGS

    do not exceed recommended dosage

  • DO NOT USE

    Do not use this product if you are now taking a prescription Monoamine Oxidase inhibitor ; MAIO,

    certain drugs for depression,psychiatric or emotional conditions, or Parkinsons Disease or for 2 weeks

    after stopping the MAIO drug,if you are uncertain whether your prescription contains an MAIO ,

    ask a health professional.

  • ASK DOCTOR

    ask a doctor before use if you have

    heart disease

    high blood pressure

    thyroid disease

    diabetes

    excessive phlegm;mucus

    difficulty in urination due to an enlarged prostate gland

    persistent or chronic cough such as occurs with smoking,asthma,chronic bronchitis or emphysema

  • STOP USE

    stop use and ask a doctor if

    nervousness,dizziness or sleeplessness occurs

    symptoms are accompanied by fever,rash,persistent headache or excessive phlegm;mucus.

    cough and congestion do not approve within 7 days or tend to recur

    these could be signs of a serious condition

  • PREGNANCY OR BREAST FEEDING

    ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    in case of overdose,get medical help or contact a Poison Control Center immediately.

  • DOSAGE & ADMINISTRATION

    directions

    Adults and Children 12 years of age and over take 1 caplet every 4 hours as needed

    children 6 to under 12 years of age consult a doctor

    do not exceed 6 doses in a 24 hour period or as directed by a doctor.

  • INACTIVE INGREDIENT

    croscarmellose sodium,hypromellose,lactose,magnesium silicate,

    magnesium stearate,maltodextrin,mycocrystalline cellulose,mineral oil,povidone,

    silica,sodium lauryl sulfate,stearic acid,titanium oxide and triacetin.

  • PRINCIPAL DISPLAY PANEL

    image of carton

  • INGREDIENTS AND APPEARANCE
    PREMIER VALUE CHEST AND SINUS CONGESTION RELIEF 
    guaifenesin/phenylephrine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-021
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin400 mg
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE10 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    LACTOSE (UNII: J2B2A4N98G)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POVIDONE (UNII: FZ989GH94E)  
    MAGNESIUM SILICATE (UNII: 9B9691B2N9)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeOVALSize17mm
    FlavorImprint Code RCCGPE;C27
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:68016-021-011 in 1 CARTON
    150 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34102/01/2006
    Labeler - Chain Drug Consortium, LLC (101668460)
    Registrant - Reese Pharmaceutical Co (004172052)
    Establishment
    NameAddressID/FEIBusiness Operations
    Reese Pharmaceutical Co004172052relabel(68016-021) , repack(68016-021)